PMC:7461420 / 36805-36987 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T202","span":{"begin":109,"end":113},"obj":"Disease"},{"id":"T203","span":{"begin":128,"end":137},"obj":"Disease"}],"attributes":[{"id":"A202","pred":"mondo_id","subj":"T202","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A203","pred":"mondo_id","subj":"T203","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"hibitor binds in a cleft between domains I and II. 125\nAs far as the development of new therapeutics against SARS‐ and MERS‐CoV infection is concerned, efforts have mainly focused on"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T430","span":{"begin":17,"end":18},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T431","span":{"begin":172,"end":179},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"}],"text":"hibitor binds in a cleft between domains I and II. 125\nAs far as the development of new therapeutics against SARS‐ and MERS‐CoV infection is concerned, efforts have mainly focused on"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T328","span":{"begin":47,"end":49},"obj":"Chemical"}],"attributes":[{"id":"A328","pred":"chebi_id","subj":"T328","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":"hibitor binds in a cleft between domains I and II. 125\nAs far as the development of new therapeutics against SARS‐ and MERS‐CoV infection is concerned, efforts have mainly focused on"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1151","span":{"begin":124,"end":137},"obj":"Disease"}],"attributes":[{"id":"A1151","pred":"tao:has_database_id","subj":"1151","obj":"MESH:D018352"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"hibitor binds in a cleft between domains I and II. 125\nAs far as the development of new therapeutics against SARS‐ and MERS‐CoV infection is concerned, efforts have mainly focused on"}

{"project":"LitCovid-sentences","denotations":[{"id":"T341","span":{"begin":51,"end":54},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"hibitor binds in a cleft between domains I and II. 125\nAs far as the development of new therapeutics against SARS‐ and MERS‐CoV infection is concerned, efforts have mainly focused on"}